News

Clinical trials are behind every approved treatment in use today. From ground-breaking therapies to everyday medications – almost every advancement made in medicine progresses through a clinical trial. Clinical trial research is a vital building block for powering progress, paving the way for new and potentially life-saving treatments and shaping global standard of blood cancer care.

Why is Research Important?

Clinical trials are vital to pursuing breakthroughs in blood cancer research. Through investigator-initiated trials, ALLG advances innovative treatments and accelerates access to therapies that improve survival rates, quality of life, and standard of care in Australian and globally.

Clinical Trials:

Build the Foundation for Future Treatments – They investigate new treatments in real world scenarios to help clinicians better understand blood cancer, improve existing therapies, develop better diagnostic tools and bring us closer to a cure.

Accelerate Access to New Treatments – Clinical trials offer patients access to new treatments not yet widely available that could improve their survival outcomes, better their quality of life and ultimately, offer hope.

Improve Outcomes – One of the more profound impacts of clinical trials is the overall health outcomes. Many new treatments can be targeted to individual patient’s cancer genome (precision medicine), with the potential for better survival, prevention of relapse and better quality of life.

Target Unmet Clinical Needs – Clinical trials are a vital way to help close the research gap in underrepresented populations, such as elderly patients or for rare blood cancers.

Have a Global Impact – Collaborating with leading international clinical trial research groups help brings new treatments to patients in Australia and New Zealand, and supports global, phase III clinical trial that are powered to change standard of care worldwide.

Expert Insights on Clinical Trials

Research Advances Outcomes for Patients

Clinical trials are at the forefront of cutting-edge research bringing the latest therapies directly to patients.

Participation in clinical trial research can provide access to treatments that are otherwise not available and can support better outcomes and improved quality of life for people with blood cancer. There are other advantages to participating in a clinical trial, with patients who participate receiving specialised, round the clock care in conjunction with our clinician researchers and clinical trial teams at their hospital.

ALLG works closely with patients to incorporate lived experience in our research design and implementation. ALLG’s Consumer Representative Panel ensures a patient-centric approach by working closely with our clinician researchers to improve patient care and progress new and innovative treatments for blood cancers. Their invaluable insights support ALLG’s leading clinical trials and contribute to research breakthroughs.

ALLG – Transforming Blood Cancer Treatment

ALLG is a not-for-profit organisation that designs and delivers doctor-led clinical trials that targeting hard-to-treat blood cancers. Our research is vital to advancing cancer research and care – translating scientific discoveries into real world applications for patients. Since 1973, our research has transformed blood cancer treatments for leukaemia, lymphoma and myeloma. With a clinical trial portfolio of 75+ active trials, we provide patients access to the most advanced therapies that shape clinical care in Australia, New Zealand and globally.

ALLG is committed to collaboration, innovation and a focus on patient needs as we deliver clinical trial research to find more effective treatments with the aim of cure.

Clinical Trials Save Lives. This Blood Cancer Awareness Month, be part of the breakthrough and donate, fundraise or raise awareness of ALLG’s vital research.